No…they’re driven by the profit motive. And the worst emotions have been scientifically proven to drive the most money in every study that would bother to touch it.
Does that mean that Sweden's approach to Covid is superior?
This is a really small sample, but in talking to my vaccine hold-out patients, I then explain options for treatment if they do get COVID. The responses are not encouraging, and usually include such phrases as "hell no", "I won't be their guinea pig" or other statements too profane to type here.A spokesman for Pfizer, Kit Longley, said that for now, the company is seeking authorization for its pill to be given only to unvaccinated people, but the company might submit amendments to that provision later, depending on the data from clinical trials."
Pfizer asks the F.D.A. to authorize its Covid antiviral pill. (Published 2021)
The treatment, Paxlovid, is the second antiviral pill to show effectiveness in treating Covid.www.nytimes.com
Here's the release from Pfizer -
Pfizer Seeks Emergency Use Authorization for Novel COVID-19 Oral Antiviral Candidate
If approved or authorized, PAXLOVID™ (PF-07321332; ritonavir) would be the first oral antiviral of its kind, a 3CL protease inhibitor specifically designed to combat SARS-CoV-2 EUA submission includes clinical data from an interim analysis of the Phase 2/3 EPIC-HR study, which demonstrated an...investors.pfizer.com
No, because they don't actually have herd immunity. They do seem to engage in different behavior during the summer into fall (I might guess because they know winter is coming and they better be outside while they can). We can check back in with them after everyone has moved inside and gathered for the holidays. They've also eliminated testing of vaccinated people so any case numbers will not be comparable to countries who test more broadly. An article from last week says testing has dropped 35% since the previous month. They say they have enough testing to still identify trends, but we'll see about that part too.
Lmao yet they're still requiring them in schools. Makes total sense. Keep up the mitigation in the places filled with the lowest-risk population.
The mayor doesn't want the backlash that would come from the teachers unions, which is what has driven most Covid policy in schools this year. It certainly hasn't been about the science. But then again, Disney claims it's okay to congregate with 30,000 of your closest friends to watch fireworks, but you're a danger walking from the door of a restaurant to your table.
Is that gonna make for a super happy, magical Disney day?!?!When even Washington, DC, one of the most liberal cities in the country run by one of the most liberal mayors in the country, realizes that it's time to drop the mask requirement, perhaps Disney should get with the program.
DC dropping indoor mask mandate Nov. 22
While some suburbs grapple with whether or not to maintain or drop indoor mask mandates, the District will drop its own indoor mask mandate starting next week.www.fox5dc.com
You really need to stop watching the kooky stations.
Jesus H…The mayor doesn't want the backlash that would come from the teachers unions, which is what has driven most Covid policy in schools this year. It certainly hasn't been about the science. But then again, Disney claims it's okay to congregate with 30,000 of your closest friends to watch fireworks, but you're a danger walking from the door of a restaurant to your table.
I know…all these poor, 30,40,50,60 years olds can’t take much more of this burden
I was not speaking of the unions influencing Disney. I was speaking of them influencing school policy around the country. And, yes, the teachers unions' are quite powerful overall, though it does vary in different parts of the country.
And for reference, 20 m^2 is 225 SF. I can’t comment on Sweden, but in the US something like a queue is going to be 5 - 7 SF per person. That’s a huge hit to capacity.
The virology people on my Twitter are discussing if this pill can be used against a broader range of coronaviruses, not just COVID. Apparently, it came out of development intended for SARS that was not pursued (presumably from lack of need). The initial consensus is that it is highly probable, and they did some testing against regular coronaviruses. This would be a significant tool to have in the arsenal in the inevitable emergence of future novel coronaviruses. Something we can give people while vaccines go through their development, study, administer phase that we didn't have this time."Pfizer has applied to the Food and Drug Administration to authorize its antiviral pill to treat unvaccinated people with Covid-19 who are at high risk of becoming severely ill, the company said on Tuesday.
The drug, which will be sold under the brand name Paxlovid, could become available within weeks if authorization is granted. It is meant to be dispensed by pharmacies and taken at home.
Paxlovid is the second antiviral pill to show effectiveness against Covid, in a new class of treatments for the disease that are expected to reach far more patients than other drugs that are typically given by infusion.
In a key clinical trial, Paxlovid was found to sharply reduce the riskof hospitalization or death when given to high-risk unvaccinated volunteers soon after they started showing symptoms. It appears to be more effective than a similar offering from Merck, known as molnupiravir, that could be authorized as soon as early December.
Both pills are geared toward older people or people who have obesity or medical conditions that put them at elevated risk for getting severely ill from Covid.
A spokesman for Pfizer, Kit Longley, said that for now, the company is seeking authorization for its pill to be given only to unvaccinated people, but the company might submit amendments to that provision later, depending on the data from clinical trials."
Pfizer asks the F.D.A. to authorize its Covid antiviral pill. (Published 2021)
The treatment, Paxlovid, is the second antiviral pill to show effectiveness in treating Covid.
Here's the release from Pfizer -
Pfizer Seeks Emergency Use Authorization for Novel COVID-19 Oral Antiviral Candidate
If approved or authorized, PAXLOVID™ (PF-07321332; ritonavir) would be the first oral antiviral of its kind, a 3CL protease inhibitor specifically designed to combat SARS-CoV-2 EUA submission includes clinical data from an interim analysis of the Phase 2/3 EPIC-HR study, which demonstrated an...
